Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21788048

Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Urol
Publication date
2011 Sep
First author
Hall SJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hall SJ
      type
      Author
    2. name
      Klotz L
      type
      Author
    3. name
      Pantuck AJ
      type
      Author
    4. name
      George DJ
      type
      Author
    5. name
      Whitmore JB
      type
      Author
    6. name
      Frohlich MW
      type
      Author
    7. name
      Sims RB
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hall SJ
      type
      Author
    2. name
      Klotz L
      type
      Author
    3. name
      Pantuck AJ
      type
      Author
    4. name
      George DJ
      type
      Author
    5. name
      Whitmore JB
      type
      Author
    6. name
      Frohlich MW
      type
      Author
    7. name
      Sims RB
      type
      Author
    bibliography ids
    1. nci-bib-5b33ce2814edfcac802d253a
    book metadata
    content sha256
    9f405e1cf79ad10056af826cdf4290cf3b5e1ba8dcda62b87e42b12fedfd305b
    document type
    citation
    dois
    1. 10.1016/j.juro.2011.04.070
    electronic publication date
    display
    2011 Jul 23
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21788048
    immutable id
    pubmed:21788048@9f405e1cf79ad10056af826cdf4290cf3b5e1ba8dcda62b87e42b12fedfd305b
    journal
    abbreviation
    J Urol
    issn electronic
    1527-3792
    issn print
    0022-5347
    issue
    3
    name
    The Journal of urology
    nlm unique id
    0376374
    pages
    877-81
    volume
    186
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21788048
      provenance
      batch id
      2529ef2eca926738ab13
      provider
      NCBI PubMed ESummary
      record sha256
      55361ccd554df123449d044908afc3249a89b1bea176101e619cc984a7437235
      response sha256
      9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
      retrieved at
      2026-09-09T23:46:42.856296+00:00
      publication date
      display
      2011 Sep
      precision
      month
      year
      2011
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21788048/
      title
      Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer.

      Preserved source evidence · Not medical advice